Pacer Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-645
| Closed | -$26K | – | 1414 |
|
|
2021
Q1 | $26K | Buy |
645
+40
| +7% | +$1.61K | ﹤0.01% | 1490 |
|
|
2020
Q4 | $27K | Sell |
605
-202
| -25% | -$9.02K | ﹤0.01% | 1468 |
|
|
2020
Q3 | $29K | Buy |
+807
| New | +$29K | ﹤0.01% | 1337 |
|
|
2020
Q2 | – | Sell |
-1,316
| Closed | -$43K | – | 944 |
|
|
2020
Q1 | $43K | Buy |
+1,316
| New | +$43K | ﹤0.01% | 557 |
|
|
2019
Q3 | – | Sell |
-2,953
| Closed | -$120K | – | 1177 |
|
|
2019
Q2 | $120K | Sell |
2,953
-1,145
| -28% | -$46.5K | ﹤0.01% | 1089 |
|
|
2019
Q1 | $124K | Buy |
4,098
+1,372
| +50% | +$41.5K | ﹤0.01% | 672 |
|
|
2018
Q4 | $92K | Buy |
2,726
+1,372
| +101% | +$46.3K | ﹤0.01% | 260 |
|
|
2018
Q3 | $57K | Buy |
1,354
+838
| +162% | +$35.3K | ﹤0.01% | 1137 |
|
|
2018
Q2 | $17K | Buy |
+516
| New | +$17K | ﹤0.01% | 1152 |
|